Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous mesenchymal stem cell-derived neural progenitors (1 trial)
Multiple Sclerosis (Phase 1)
Multiple Sclerosis, Chronic Progressive (Phase 1)
Neoplasm Metastasis (Phase 1)
Sclerosis (Phase 1)
Trials (1 total)
Trial APIs (1 total)